Australia: CTX Scheme Renamed CTA Scheme
November 11, 2020
On November 6, 2020, Australia's Therapeutic Goods Administration (TGA) announced that it has changed the name of the Clinical Trial Exemption (CTX) scheme to the Clinical Trial Approval (CTA) scheme.
The name change from CTX to CTA does not involve any process changes, and all online information and application forms have been updated accordingly.
The ClinRegs team will update the profile accordingly.
For details on all of Australia's clinical research regulatory requirements, view the Australia country profile.